Skip to content
Screener

Kestra Medical Technologies KMTS Retained Earnings

Retained Earnings at other companies

Abbott logo
AbbottABT
$49.79B+2.7%
Boston Scientific logo
Boston ScientificBSX
$6.91B+107%
Medtronic logo
MedtronicMDT
$32.64B+3.7%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
-$817.76M-1.7%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
-$259.36M-34.1%
Haemonetics logo
HaemoneticsHAE
$311.52M-12.5%

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Market cap$1.55B+106%
Enterprise value$1.49B+151%
P/S16.3×+4.9×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Reported directly by Kestra Medical Technologies in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 5:16 PM EDT
Fiscal year
FY2026
Accession
0001193125-26-303397
Line itemApril 30, 2026April 30, 2025
Commitments and contingencies (Note 14)
Shareholders’ equity
Common Shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2026 and April 30, 2025; 58,383,924 issued and outstanding as of April 30, 2026 and 51,348,656 shares issued and outstanding as of April 30, 202558,38451,349
Additional paid-in capital853,353674,306
Accumulated other comprehensive loss(218)—
Accumulated deficit(651,861)(520,249)
Total shareholders’ equity259,658205,406
Total liabilities and shareholders’ equity$358,465$295,744

Item 16. Form 10-K Summary.

FAQ

What is Kestra Medical Technologies's retained earnings?
Kestra Medical Technologies (KMTS) reported retained earnings of -$651.86M in Q1 2026.
How has Kestra Medical Technologies's retained earnings changed year-over-year?
Kestra Medical Technologies's retained earnings decreased by 25.3% year-over-year, from -$520.25M to -$651.86M.
What is the long-term trend for Kestra Medical Technologies's retained earnings?
Over 2 years (2024 to 2026), Kestra Medical Technologies's retained earnings has grown at a 26.6% compound annual growth rate (CAGR), from -$406.44M to -$651.86M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ask your AI about Kestra Medical Technologies's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude